SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-022195
Filing Date
2023-05-15
Accepted
2023-05-15 16:06:33
Documents
14
Period of Report
2023-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bior-20230515.htm   iXBRL 8-K 61457
2 EX-99.1 bior-ex99_1.htm EX-99.1 311139
3 GRAPHIC img208566971_0.jpg GRAPHIC 19299
  Complete submission text file 0000950170-23-022195.txt   542564

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bior-20230515_pre.xml EX-101.PRE 11540
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bior-20230515.xsd EX-101.SCH 2489
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bior-20230515_lab.xml EX-101.LAB 18128
8 EXTRACTED XBRL INSTANCE DOCUMENT bior-20230515_htm.xml XML 4896
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 23922100
SIC: 2834 Pharmaceutical Preparations